Chester County News and Community Website
WILMINGTON, DE — Ashland Inc. (NYSE: ASH) has finalized the sale of its nutraceuticals division to Turnspire Capital Partners LLC, effective August 30, 2024. This transaction includes custom formulation and contract …
Ashland Inc. Sells Nutraceuticals Business to Turnspire Capital Partners Read More WILMINGTON, DE — The board of directors of Ashland Inc. (NYSE: ASH) has announced a quarterly cash dividend of $0.405 per share on the company’s common stock. The dividend will …
Ashland Inc. Declares Quarterly Dividend Read More WILMINGTON, DE — Ashland Inc. (NYSE: ASH) announced its third quarter fiscal year 2024 financial results, ending June 30, 2024. The company, which specializes in additives and specialty ingredients, reported …
Ashland’s Fiscal Report: Resilience Amid Market Shifts Read More WILMINGTON, DE — Ashland Inc. (NYSE: ASH) announced this week that Omar Irani will join the company as vice president of strategy, mergers and acquisitions, and portfolio management. His new …
Ashland Inc. Appoints Omar Irani as Vice President of Strategy and M&A Read More WILMINGTON, DE — Ashland Inc. (NYSE: ASH) has announced that it has strengthened its commitment to environmental, social, and governance (ESG) practices through a new partnership with the Fair Wage …
Ashland Inc. Achieves Global Living Wage Certification Read More WILMINGTON, DE — Ashland Inc. (NYSE: ASH) has announced that Alessandra Faccin will join the company as senior vice president and general manager of its Life Sciences division, effective June …
Ashland Inc. Appoints Alessandra Faccin as Senior VP and General Manager, Life Sciences Read More WILMINGTON, DE — Ashland Inc. (NYSE: ASH), a global leader in specialty chemical solutions, announced this week the appointment of Ashish K. Kulkarni to its Board of Directors, effective May …
Ashland Inc. Welcomes Tech Innovator Ashish K. Kulkarni to its Board of Directors Read More WILMINGTON, DE — Ashland Inc. (NYSE: ASH), a global specialty chemicals company, has reached an agreement to divest its nutraceuticals business to private equity firm Turnspire Capital Partners LLC. The …
Ashland Inc. Sells Nutraceuticals Division to Turnspire Capital Read More WILMINGTON, DE — Ashland Inc. (NYSE: ASH) announced a 5% increase in its quarterly cash dividend to $0.405 per share, payable on June 15, 2024, to stockholders of record as …
Ashland Inc. Raises Quarterly Dividend by 5% Read More WILMINGTON, DE — Ashland Inc. (NYSE: ASH) has unveiled its financial performance for fiscal Q2 2024, coupled with an outlook for Q3 and the full fiscal year.
Ashland Inc. Navigates Market Dynamics Amidst Modest Sales, Eyeing an Economic Resurgence Read More